Glioblastoma, IDH-wildtype, CNS WHO grade 4, is a highly aggressive primary tumor of the central nervous system characterized by infiltrative growth, marked antigenic heterogeneity, and resistance to treatment. Despite advances in immunotherapy, clinical responses of glioblastoma remain transient and non-durable. Emerg...
Tyler Lo, Armando Bunjaj, Jeffrey P. Turnbull et al.· Oncology Reviews· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.